Thomas Nathaniel to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Thomas Nathaniel has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.612
-
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.
Score: 0.612
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.